Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that the company will participate in BIO International Convention 2026, taking place June 22–25, 2026, in San Diego, US. Cereno Scientific will also deliver a company presentation during the conference.
BIO International Convention is one of the world’s largest and most comprehensive biotechnology events, bringing together more than 20,000 industry leaders from across the global biotech ecosystem. The event provides a premier platform for discussions with pharmaceutical companies, investors and strategic partners as Cereno Scientific continues to advance its HDAC inhibitor platform and clinical pipeline toward key value-inflection points.
"BIO International Convention is one of the most important global partnering events for the biotech industry. As we continue preparations for the start of the Phase IIb trial of CS1 and advance CS014 toward Phase II development, we look forward to engaging with pharmaceutical companies, investors and other stakeholders interested in innovative disease-modifying therapies for rare cardiovascular and pulmonary diseases. We believe our HDAC inhibitor platform represents a differentiated opportunity with the potential to address the underlying drivers of disease through epigenetic modulation,” said Sten R. Sörensen, CEO of Cereno Scientific.
During the conference, Cereno Scientific will deliver a company presentation highlighting recent clinical progress, upcoming development milestones and the broader potential of the company’s HDAC inhibitor platform.
Company presentation:
Presenter: Sten R. Sörensen, CEO
Date: Monday June 22, 2026
Time: 4:00 PM PT
Venue: Theater 4 at the San Diego Convention Center
Sten R. Sörensen, CEO, Rahul Agrawal, CMO & Head of R&D, and Jeppe Øvlesen, Chair of the Board, will attend the conference and participate in partnering meetings throughout the event. To book a meeting with Cereno Scientific, please contact business.development@cerenoscientific.com or connect with the team via the BIO Partnering™ platform.
BIO is the world’s largest advocacy association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 countries worldwide. The BIO International Convention is the organization’s flagship event and a global forum for partnering, investment and innovation in biotechnology.